PPP2R5D and neurodevelopmental disorder: Although the GMFM has not yet been validated for use in individuals with this rare genetic disease, many of the impairments seen in individuals diagnosed with PPP2R5D related neurodevelopmental disorder closely resemble those with SMA and DS, specifically hypotonia and developmental delay.